Novo Integrated Sciences

NVOS

Medical - Care Facilities · Healthcare

Exchange

Other OTC

Winston Score

Winston is worried

Below-average fundamentals — multiple weak pillars.

Data as of Aug 23, 2026 · filings through Aug 31, 2024

How the score breaks down

Quality

Weak

Growth

Mixed

Cash Flow

Weak

Stability

Mixed

Valuation

Data not available

Track this stock — start free trial

Winston Score History

The full picture

Novo Integrated Sciences is a small healthcare company that provides outpatient medical and wellness services to everyday patients. Its core offerings include physiotherapy, chiropractic care, massage therapy, and other rehabilitation services. The company operates primarily in Canada, running a network of community-based clinics that serve patients looking for non-hospital care.

The company earns revenue mainly by charging fees for in-person clinical visits and therapy sessions, with some additional income from ancillary health services. It is a very small company with a market cap near zero, and it faces intense competition from both large healthcare networks and independent local clinics. The operating margin is deeply negative, meaning the company spends far more than it earns, which is the central risk — it must significantly grow patient volume or cut costs to reach profitability, and there is no clear evidence yet that it has a durable competitive advantage to help it do so.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-6.7% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+230.0% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

6.6%ownership

Insiders own a meaningful stake in the company

Cash Runway

~5 months

$844,584 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Novo Integrated Sciences has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

51.2%

Healthy — 51.2% gross margin

Profit after running costs

Operating Margin

-30.4%

Losing money on operations — -30.4%

Return on the money invested

ROCE

-42.4%

Weak — -42.4% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+5.7%

Slow sales growth (+5.7% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-38.2%

Burning cash (-38.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.32

Conservative — low debt load (0.32)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial